Heritage Financial Corporation (HFWA)
NASDAQHealth CareBanks - RegionalSnapshot 2026-09-04
NASDAQHealth CareBanks - RegionalSnapshot 2026-09-04
Broken: Primary pillar broken — Achieve revenue growth near 8.7% next 12 months: rev +7.8% vs 8% target.
Heritage Financial grew net income to $18.95 million in Q1 2026 from $13.91 million in Q1 2025. Operating income rose to $22.39 million in Q1 2026 from $16.16 million in Q1 2025. The company maintains a steady quarterly dividend of $0.24 per share. Analysts expect about 9% revenue growth next year.
Revenue growth could slow below the 8.7% consensus. Operating income and net income may fail to keep rising from recent levels near $22 million and $19 million. Cybersecurity risks could hurt the company’s reputation and costs.
The price sits about 4% above our 12-month fair value near $28. Analysts expect about 9% revenue growth. Our view aligns with these expectations and sees stable dividend and income growth.
Breaks if: dividend falls below $0.24 per share in any quarter
Breaks if: net income falls below $18 million in any quarter after Q1 2026
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
HFWA represents a durable compounder with a focus on steady growth and profitability. The current thesis state is intact, supported by strong recent financial performance and effective management execution.
The market appears to have priced in a justified valuation, with low fragility and no significant expectations gap. HFWA's valuation is aligned with peers, suggesting that the current price reflects its stable fundamentals.
Management is on track to complete the integration of the Olympic acquisition, which should lead to cost savings and improved profitability. Recent financial results show strong growth in net and operating income, indicating a positive trajectory.
Key factors include the potential for guidance cuts in upcoming calls and the impact of broader economic conditions, such as job growth and sector performance from major healthcare companies. Monitoring these scenarios will be crucial for the thesis.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports a more favorable outlook. There are no new threats impacting the thesis at this time.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Focus on enhancing net income through operational improvements.
Breaks if: operating income falls below $22 million in any quarter after Q1 2026
Improve operating income through efficiency and revenue growth.
Breaks if: revenue growth falls below 7% in FY 2026
Improve operating income through efficiency and revenue growth.
Overall, HFWA's fundamentals and management execution support a positive long-term view, but external economic factors could influence its performance. Not investment advice.